SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-04-15 17:35
Tx date 2021-04-12
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-931,143.50
-805,000 vol
$1.16 each
1,459,580
Filed 2021-04-15 17:34
Tx date 2021-04-12
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
51 - Exercise of options
$57,950
+305,000 vol
$0.19 each
2,264,580
Filed 2021-04-15 17:30
Tx date 2021-04-12
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
51 - Exercise of options
$215,000
+500,000 vol
$0.43 each
1,959,580
Filed 2021-04-15 17:28
Tx date 2021-04-12
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
51 - Exercise of options
$-57,950
-305,000 vol
$0.19 each
4,145,000
Filed 2021-04-15 17:27
Tx date 2021-04-12
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
51 - Exercise of options
$-215,000
-500,000 vol
$0.43 each
4,450,000
Filed 2021-01-04 12:01
Tx date 2020-09-29
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$33,000
+300,000 vol
$0.11 each
2,450,000
Filed 2021-01-04 11:59
Tx date 2020-12-31
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$575,000
+2,500,000 vol
$0.23 each
4,650,000
Filed 2020-03-15 12:15
Tx date 2020-03-13
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$142,500
+750,000 vol
$0.19 each
2,150,000
Filed 2019-12-31 11:52
Tx date 2019-09-16
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$215,000
+500,000 vol
$0.43 each
1,400,000
Filed 2019-01-15
Tx date 2018-12-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
52 - Expiration of options

-600,000 vol
0
Filed 2019-01-15
Tx date 2019-01-10
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$1,368,000
+900,000 vol
$1.52 each
900,000
Filed 2018-04-25
Tx date 2018-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
51 - Exercise of options
$-26,000
-104,000 vol
$0.25 each
1,596,000
Filed 2018-04-25
Tx date 2018-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
51 - Exercise of options
$26,000
+104,000 vol
$0.25 each
1,459,580
Filed 2018-04-25
Tx date 2018-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
52 - Expiration of options
$-249,000
-996,000 vol
$0.25 each
600,000
Filed 2018-04-03
Tx date 2018-03-29
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
51 - Exercise of options
$1,375,000
+500,000 vol
$2.75 each
1,355,580
Filed 2018-04-03
Tx date 2017-08-14
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$1,650,000
+600,000 vol
$2.75 each
Filed 2018-04-03
Tx date 2018-03-29
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
51 - Exercise of options
$-1,375,000
-500,000 vol
$2.75 each
1,700,000
Filed 2018-04-03
Tx date 2017-08-14
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$1,375,000
+500,000 vol
$2.75 each
2,200,000
Filed 2017-09-08
Tx date 2017-08-14
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$1,650,000
+600,000 vol
$2.75 each
2,300,000
Filed 2017-08-03
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Mia Kay DeLaBarre (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-03
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Brody Richard DeLaBarre (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-03
Tx date 2017-08-03
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Brody Richard DeLaBarre (Control or Direction)
Common Shares
47 - Acquisition or disposition by gift

+1,000 vol
1,000
Filed 2017-08-03
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charlotte Ray Morley (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-03
Tx date 2017-08-03
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charlotte Ray Morley (Control or Direction)
Common Shares
47 - Acquisition or disposition by gift

+1,000 vol
1,000
Filed 2017-08-03
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jaxon Morgan DeLaBarre (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-03
Tx date 2017-08-03
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jaxon Morgan DeLaBarre (Control or Direction)
Common Shares
47 - Acquisition or disposition by gift

+1,000 vol
1,000
Filed 2017-08-03
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Josephine Cooper Morley (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-03
Tx date 2017-08-03
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Josephine Cooper Morley (Control or Direction)
Common Shares
47 - Acquisition or disposition by gift

+1,000 vol
1,000
Filed 2017-08-03
Tx date 2017-08-03
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Mia Kay DeLaBarre (Control or Direction)
Common Shares
47 - Acquisition or disposition by gift

+1,000 vol
1,000
Filed 2016-12-23
Tx date 2016-12-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+600,000 vol
1,700,000
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+1,100,000 vol
1,100,000
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$12,979
+259,580 vol
$0.05 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$12,979
+259,580 vol
$0.05 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$12,979
+259,580 vol
$0.05 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
50 - Grant of options
$275,000
+1,100,000 vol
$0.25 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
50 - Grant of options
$275,000
+1,100,000 vol
$0.25 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
50 - Grant of options
$275,000
+1,100,000 vol
$0.25 each
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
855,580
Filed 2016-05-05
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-28
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$12,979
+259,580 vol
$0.05 each
1,915,580
Filed 2016-04-28
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
50 - Grant of options
$275,000
+1,100,000 vol
$0.25 each
1,656,000
Filed 2016-04-28
Tx date 2016-04-21
$ZOM
Zomedica Pharmaceuticals Corp.
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
556,000